Fundraising FoxU.S. Venture Partners — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Adaptive provides a cloud cost optimization platform that detects, remediates, and prevents "shadow waste" and inefficiencies across multi-cloud, Kubernetes, AI platforms, data cloud, and code.
AI & Machine LearningCloud ComputingDeveloper Tools
Aviv Revach(CEO)inEyal Brosh(Founder)in
Co-investorsForgePoint CapitalLaunchpad CapitalNew Era Capital PartnersUS Venture PartnersVertex Ventures IsraelNew Era Capital+2 more
Cagent Vascular develops endovascular medical devices, including the Serranator PTA Serration Balloon Catheter, for the treatment of vascular disease.
HardwareHealthtechMedical DevicesWayne, US
Brian Walsh(Chairman & CEO)inPeter Johansson(Chief Quality & Compliance Officer, VP Engineering)inPaul Wilson(Chief Commercial Officer)inMatt Condron(SVP of Operations)inCorey Latanision(SVP of Marketing & International Sales)inPeter Schneider(Chief Medical Advisor, Co-Founder)
Co-investorsUS Venture PartnersAstoria Health Investors
Human Interest provides a software platform for 401(k) retirement savings plans, designed to help small and mid-sized businesses offer affordable retirement benefits to their employees.
Enterprise SoftwareFintechHR TechSaaSSan Francisco, US
Roger Lee(CEO)inPaul Sawaya(CTO)inJeff Schneble(Chief Executive Officer)inTripp Faix(Executive Officer)inYoyo Zhou(Engineering Manager)Michael Shinn(Technical Recruiter)
Co-investorsAlumni VenturesBetter Tomorrow VenturesFundersClubGlynn Capital ManagementGreat Oaks Venture CapitalImmeasurable+35 more
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesJoyance PartnersLumira VenturesShangBay Capital LLCUS Venture PartnersAmzak Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.